The implications of Industry-Funded Disease Awareness Campaigns in the Rare Disease Setting

Mayo Clin Proc. 2021 Sep;96(9):2305-2308. doi: 10.1016/j.mayocp.2020.12.041.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Approval*
  • Drug Industry / legislation & jurisprudence
  • Health Promotion
  • Humans
  • Rare Diseases / diagnosis
  • Rare Diseases / drug therapy*